Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin Gel for Gingival Augmentation
NCT05683782Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Oct 2022
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of erythropoietin chitosan gel in gingival recession (2 arms), sponsored by Ain Shams University. Primary endpoints: Wound healing at 21 days and Patient Satisfaction at 1 month. Status: unknown.
02
Drugs
erythropoietin chitosan gel
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT05683782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683782.